According to Millennium Research Group’s new US Markets for Spinal Implants 2009 report, the US spinal nonfusion technology segment will see an increase in procedure volumes through 2013 largely at the expense of traditional spinal fusion.
Products
Cordis Celebrates 50 Years of Transforming Cardiovascular Care
Cordis Corporation, a leading developer and manufacturer of breakthrough treatments for cardiovascular disease, is celebrating its 50th anniversary this month.
Hip Resurfacing Championed as a Bone-Preserving Alternative to Total Hip Replacement
According to Millennium Research Group’s US Markets for Large-Joint Reconstructive Implants 2009 report, hip resurfacing will be the fastest-growing segment of the large-joint reconstructive implant market through 2013, rising at a compound annual growth rate of over 25%.
OrSense Receives European CE Mark Approval For New Monitoring System
OrSense Ltd. announced today that it has received a European CE Mark approval for its NBM-200MP, a Continuous Non-Invasive Hemoglobin And Pulse Oximetry Monitoring System.
Covidien Receives FDA Clearance For New Pulse Oximeter With OxiMax SPD™ Alert
Covidien announced today that the United States Food and Drug Administration has issued a 510(k)marketing clearance for the Nellcor™ OxiMax™ N-600x™ pulse oximeter with OxiMax SPD™ alert.
Physical Activity Monitor Revolutionises Hip And Knee Surgery
A revolutionary new physical activity monitoring system which compares actual patient activity with researched norms for individual patient types has been unveiled to support orthopaedic surgeons and GPs in their decision making processes along the care pathway.
NeuroVasx Receives CE Mark for cPAX Aneurysm Treatment System
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received CE Mark for the cPAX Aneurysm Treatment System.
Spinal Elements, Inc. and Paradigm BioDevices, Inc. Form Strategic Alliance
Spinal Elements® has formed a strategic alliance with Paradigm BioDevices to assist in the expansion of the distribution network for Spinal Elements products, including the Magnum+™, a new stand-alone anterior lumbar interbody fusion device.
NovaLign nabs FDA approval for bone fixation system
NovaLign Orthopedics Inc. can now market its first product, a bone fixation system, after it received clearance from the Food and Drug Administration.
Abbott Advances its Revolutionary Fully Bioabsorbable Drug Eluting Stent with Initiation of Next Phase of Clinical Trial
Abbott today announced the initiation of the next phase of the ABSORB clinical trial to evaluate the safety and performance of the company’s fully bioabsorbable drug eluting coronary stent.
Drug Firm Nycomed Seeks Buyer Or Partner
Nycomed, a privately held Swiss drug company, is looking for potential buyers in a deal that could be valued at as much as €10 billion ($13.57 billion), according to people familiar with the matter.
New Study Reconfirms Long-Term Strength of Biodesign Hernia Graft
A five-year study confirms the long-term strength and durability of the Biodesign™ Hernia Graft, Cook Medical, a world leader in advanced tissue repair, announced today.
Ardian Completes $47 Million Financing Led by Medtronic to Develop Hypertension Treatment
Ardian, Inc., developer of a breakthrough catheter-based medical device to treat hypertension, announced today that Medtronic, Inc., one of the world’s leading medical technology companies, has led a $47 million financing of the company.
IlluminOss™ Photodynamic Bone Stabilization System Receives CE Mark
IlluminOss Medical Inc., a medical device company developing the innovative IlluminOss™ Photodynamic Bone Stabilization System for orthopedic surgery, today announced that it had been granted a CE Mark.
ACell and Medline Announce Exclusive Marketing and Distribution Agreement for MatriStem™
ACell, Inc. and Medline Industries, Inc. jointly announced today that Medline has signed an exclusive marketing and distribution agreement for ACell’s MatriStem™ Wound Care Matrix.
Covidien Receives FDA Clearance for the Nellcor™ OxiMax™ N-600x™ Pulse Oximeter with OxiMax SPD™ Alert
Covidien, a leading global provider of healthcare products, today announced that the United States Food and Drug Administration has issued a 510(k)marketing clearance for the Nellcor™ OxiMax™ N-600x™ pulse oximeter with OxiMax SPD™ alert for adults.